Average Co-Inventor Count = 7.16
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Aktiengesellschaft (19 from 12,157 patents)
2. Bayer Intellectual Property Gmbh (6 from 721 patents)
3. Adverio Pharma Gmbh (5 from 20 patents)
4. Bayer Pharma Aktiengesellschaft (4 from 378 patents)
5. Bayer Schering Pharma Ag (2 from 192 patents)
6. Bayeraktiengesellschaft (2 from 38 patents)
38 patents:
1. 12064429 - Substituted 5-fluoro-1H-pyrazolopyridines and their use
2. 11439642 - Substituted 5-fluoro-1H-pyrazolopyridines and their use
3. 10736896 - Substituted 5-fluoro-1H-pyrazolopyridines and their use
4. 10053428 - 5-aminotetrahydroquinoline-2-carboxylic acids and their use
5. 9993476 - Substituted 5-flouro-1H-pyrazolopyridines and their use
6. 9688636 - 5-aminotetrahydroquinoline-2-carboxylic acids and their use
7. 9309239 - Substituted 6-fluoro-1H-pyrazolo[4,3-b]pyridines and use thereof
8. 9266885 - Substituted 5-fluoro-1H-pyrazolopyridines and their use
9. 8981104 - 5-aminotetrahydroquinoline-2-carboxylic acids and their use
10. 8921377 - Substituted 5-fluoro-1H-pyrazolopyridines and their use
11. 8420656 - Substituted 5-fluoro-1H-pyrazolopyridines and their use
12. 8334291 - Aliphatically substituted pyrazolopyridines, and the use thereof
13. 8329716 - Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors
14. 8309551 - Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders
15. 8114400 - Aza-bicyclic compounds and their use as stimulators of soluble guanylate cyclase